The FAA took additional steps to prevent helicopter-plane collisions such as the one that killed 67 people last week. NBC News' Tom Costello reports.Feb. 5, 2025 ...

This is ideal for short term utilisation of a waiver while awaiting approval or seeking to gain operational experience prior to obtaining your own waiver. With a background in drone operations ...

Parents are often searching for the automotive holy grail: a car that’s not a minivan and can fit three child-safety seats across the backseat. In our Car Seat Checks, we’ve found the answer ...

Known for their premium baby items, Nuna have announced the latest car seat to their collection with the lightweight, ARRA ...

The FAA has notified airlines that is cutting the number of arrivals at Washington’s Reagan National Airport after a mid-air collision killed 67 people. Elon Musk also says he will help overhaul ...

The Tesla Full Self-Driving crowdsourced dataset that Elon Musk has approved has doubled since the CEO shared it last month. What does it say about the state of Tesla’s Full Self-Driving program ...

According to the available trends, the party, which was leading in the early rounds of counting from the Badli seat, is trailing in all constituencies. The Congress, which ruled the national ...

“[Try] seatbelts for light bondage, seat adjustments for different angles, and [the] radio to set the mood.” Before you pull over into pound town, here’s how to master the art of amazing car ...

In the end, the FDA took little more than six weeks to give final approval to Kymriah, the first ever CAR-T treatment. The US regulators’ advisors recommended the drug last month, and now the ...

AIM ImmunoTech (AIM) announced Safety Committee approval to proceed with the Phase 2 portion of the Phase 1b/2 clinical trial involving AIM’s Ampligen and AstraZeneca’s (AZN) anti-PD-L1 immune ...

Incyte and MorphoSys' antibody therapy tafasitamab has been approved in Europe, promising to provide a more convenient alternative to expensive and cumbersome CAR-T therapies for patients with ...

The condition impacts approximately 6 million Americans and currently has no FDA-approved therapies. Expanded Access Programs allow patients who have unmet medical needs with serious or life ...